Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$6.49M
6 trades · 2 insiders
Net · 90d
$-6.49M
Insiders on file
22
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Loggia Nicoletta | Director | 8 | $0 | $0 | 2026-09-30 |
| Manning Paul B | Director, 10% Owner | 23 | $23.91M | $0 | 2026-09-30 |
| PAPA JOSEPH C | Director | 11 | $73.1K | $0 | 2026-09-30 |
| Tak Paul Peter | Chief Executive Officer, Director | 28 | $230.0K | $7.37M | 2026-09-11 |
| Zimmermann Martine | Director | 2 | $0 | $0 | 2026-09-08 |
| Tyagarajan Seshu | See Remarks | 23 | $25.1K | $1.28M | 2026-08-17 |
| Sims Mark E. | Chief Commercial Officer | 1 | $0 | $0 | 2026-07-06 |
| Barone Francesca | Chief Scientific Officer | 19 | $2.0K | $994.8K | 2026-06-29 |
| Radhakrishnan Maha | Director | 2 | $0 | $0 | 2026-06-23 |
| Martell Christopher | Director | 13 | $1.10M | $0 | 2026-06-23 |
| Nabel Gary J. | Director | 6 | $0 | $0 | 2026-06-23 |
| Nguyen Diem | Director | 6 | $80.0K | $0 | 2026-06-23 |
| Gaeta Renee | Director | 5 | $0 | $0 | 2026-06-23 |
| Benz Edward J. JR | Director | 5 | $0 | $0 | 2026-06-23 |
| Schoch Charles | See Remarks | 9 | $0 | $311.9K | 2026-01-26 |
| Nichols William Garrett | Chief Medical Officer | 23 | $0 | $763.8K | 2026-01-26 |
| Aguilar-Cordova Estuardo | Director, 10% Owner | 22 | $0 | $486.5K | 2025-02-21 |
| Aguilar Laura K. | Chief Medical Officer | 37 | $0 | $0 | 2024-12-27 |
| Amello Jason | Chief Financial Officer | 7 | $10.0K | $0 | 2023-11-28 |
| Stewart Susan B. | Chief Regulatory Officer | 1 | $0 | $0 | 2022-04-11 |
| Canepa John J | Chief Financial Officer | 2 | $81.0K | $0 | 2022-02-28 |
| Caffo Nathan | Chief Business Officer | 1 | $48.0K | $0 | 2021-07-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Loggia Nicoletta | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 380 | $8.68 | $3.3K | 380 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 1,325 | $8.68 | $11.5K | 1,325 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 2,189 | $8.68 | $19.0K | 2,189 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2026-09-11 | 2026-09-11 | 59,379 | $10.46 | $621.1K | 113,321 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer, Dir | S Sale | 2026-09-11 | 2026-09-11 | 59,379 | $10.46 | $620.9K | 113,321 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | M Exercise deriv | 2026-09-10 | 2026-09-11 | 125,000 | — | $0 | 1,638,968 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2026-09-10 | 2026-09-11 | 220,866 | $11.50 | $2.54M | 172,700 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | M Exercise | 2026-09-10 | 2026-09-11 | 125,000 | $1.55 | $193.8K | 393,566 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer, Dir | M Exercise deriv | 2026-09-10 | 2026-09-11 | 125,000 | — | $0 | 1,638,968 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer, Dir | S Sale | 2026-09-10 | 2026-09-11 | 220,866 | $11.50 | $2.54M | 172,700 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer, Dir | M Exercise | 2026-09-10 | 2026-09-11 | 125,000 | $1.55 | $193.8K | 393,566 | SEC↗ |
| Zimmermann Martine | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 64,000 | — | $0 | 64,000 | SEC↗ |
| Zimmermann Martine | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 64,000 | — | $0 | 64,000 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2026-08-17 | 2026-08-19 | 7,000 | $12.00 | $84.0K | 76,865 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2026-08-17 | 2026-08-19 | 7,000 | $12.00 | $84.0K | 76,865 | SEC↗ |
| Sims Mark E. | Chief Commercial Officer | A Award deriv | 2026-07-06 | 2026-07-08 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2026-06-30 | 2026-07-01 | 381 | $8.64 | $3.3K | 381 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2026-06-30 | 2026-07-01 | 1,331 | $8.64 | $11.5K | 1,331 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2026-06-30 | 2026-07-01 | 2,199 | $8.64 | $19.0K | 2,199 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2026-06-29 | 2026-07-01 | 7,000 | $10.02 | $70.1K | 83,865 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2026-06-29 | 2026-07-01 | 23,447 | $10.06 | $235.9K | 77,362 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Nguyen Diem | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Nabel Gary J. | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Gaeta Renee | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Martell Christopher | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2026-03-31 | 2026-04-02 | 779 | $4.11 | $3.2K | 779 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2026-03-31 | 2026-04-02 | 2,795 | $4.11 | $11.5K | 2,795 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2026-03-31 | 2026-04-02 | 4,618 | $4.11 | $19.0K | 4,618 | SEC↗ |
| Manning Paul B | Director | P Buy | 2026-02-23 | 2026-02-26 | 550,458 | $5.45 | $3.00M | 2,763,527 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 232,000 | — | $0 | 232,000 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 629,000 | — | $0 | 629,000 | SEC↗ |
| Schoch Charles | Chief Financial Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 232,000 | — | $0 | 232,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 136,500 | — | $0 | 136,500 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 154,000 | — | $0 | 154,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise deriv | 2025-07-28 | 2025-07-30 | 937 | — | $0 | 29,377 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2025-07-28 | 2025-07-30 | 937 | $6.98 | $6.5K | 52,493 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise | 2025-07-28 | 2025-07-30 | 937 | $1.29 | $1.2K | 53,430 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise deriv | 2025-06-30 | 2025-07-02 | 781 | — | $0 | 30,314 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2025-06-30 | 2025-07-02 | 781 | $5.04 | $3.9K | 52,493 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise | 2025-06-30 | 2025-07-02 | 781 | $1.29 | $1.0K | 53,274 | SEC↗ |
| PAPA JOSEPH C | Director | A Award | 2025-06-25 | 2025-06-26 | 64,239 | $4.67 | $300.0K | 64,239 | SEC↗ |
| Nabel Gary J. | Director | A Award | 2025-06-25 | 2025-06-26 | 5,353 | $4.67 | $25.0K | 5,353 | SEC↗ |
| Schoch Charles | Chief Financial Officer | A Award | 2025-06-25 | 2025-06-26 | 5,353 | $4.67 | $25.0K | 43,391 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award | 2025-06-25 | 2025-06-26 | 4,282 | $4.67 | $20.0K | 100,809 | SEC↗ |
| Loggia Nicoletta | Director | A Award | 2025-06-25 | 2025-06-26 | 2,141 | $4.67 | $10.0K | 2,141 | SEC↗ |
| Martell Christopher | Director | A Award | 2025-06-25 | 2025-06-26 | 111,349 | $4.67 | $520.0K | 111,349 | SEC↗ |
| Manning Paul B | Director | A Award | 2025-06-25 | 2025-06-26 | 1,070,663 | $4.67 | $5.00M | 2,213,069 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award | 2025-06-25 | 2025-06-26 | 42,826 | $4.67 | $200.0K | 268,566 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | A Award | 2025-06-25 | 2025-06-26 | 5,353 | $4.67 | $25.0K | 90,865 | SEC↗ |
| Schoch Charles | Chief Financial Officer | A Award deriv | 2025-06-20 | 2025-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nguyen Diem | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nabel Gary J. | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Martell Christopher | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Gaeta Renee | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 28,480 | — | $0 | 28,480 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2025-03-19 | 2025-03-20 | 400 | $9.00 | $3.6K | 225,740 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | M Exercise deriv | 2025-03-18 | 2025-03-20 | 18,000 | — | $0 | 30,822 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise deriv | 2025-03-18 | 2025-03-20 | 13,905 | — | $0 | 31,095 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise deriv | 2025-03-18 | 2025-03-20 | 4,584 | — | $0 | 195,416 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2025-03-18 | 2025-03-20 | 25,772 | $8.77 | $226.0K | 226,140 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2025-03-18 | 2025-03-20 | 32,146 | $8.76 | $281.6K | 96,527 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | M Exercise | 2025-03-18 | 2025-03-20 | 18,000 | $1.55 | $27.9K | 128,673 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2025-03-18 | 2025-03-20 | 45,316 | $8.76 | $397.0K | 52,493 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise | 2025-03-18 | 2025-03-20 | 13,905 | $1.29 | $17.9K | 97,809 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | M Exercise | 2025-03-18 | 2025-03-20 | 4,584 | $3.75 | $17.2K | 83,904 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | M Exercise deriv | 2025-03-17 | 2025-03-19 | 20,000 | — | $0 | 70,000 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | M Exercise deriv | 2025-03-17 | 2025-03-20 | 20,000 | — | $0 | 70,000 | SEC↗ |
| Schoch Charles | See Remarks | S Sale | 2025-03-17 | 2025-03-19 | 5,000 | $8.83 | $44.1K | 38,038 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2025-03-17 | 2025-03-19 | 31,278 | $8.82 | $275.9K | 85,512 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | M Exercise | 2025-03-17 | 2025-03-20 | 20,000 | $1.29 | $25.8K | 116,790 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2025-03-17 | 2025-03-20 | 31,278 | $8.82 | $275.9K | 85,512 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2025-02-21 | 2025-02-25 | 10,582 | $12.02 | $127.2K | 120,861 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2025-02-21 | 2025-02-25 | 10,583 | $12.02 | $127.2K | 162,929 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award deriv | 2025-02-12 | 2025-02-14 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award deriv | 2025-02-12 | 2025-02-14 | 525,000 | — | $0 | 525,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award deriv | 2025-02-12 | 2025-02-14 | 107,250 | — | $0 | 107,250 | SEC↗ |
| Schoch Charles | See Remarks | A Award deriv | 2025-02-12 | 2025-02-14 | 83,000 | — | $0 | 83,000 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | A Award deriv | 2025-02-12 | 2025-02-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2025-02-10 | 2025-02-13 | 31,335 | $8.61 | $269.8K | 60,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2025-01-15 | 2025-01-17 | 10,428 | $7.23 | $75.4K | 79,320 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2025-01-15 | 2025-01-17 | 21,704 | $7.23 | $156.9K | 251,912 | SEC↗ |
| Schoch Charles | See Remarks | S Sale | 2025-01-15 | 2025-01-17 | 9,511 | $7.23 | $68.8K | 43,038 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2025-01-15 | 2025-01-17 | 13,534 | $7.23 | $97.9K | 110,673 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2025-01-15 | 2025-01-17 | 14,322 | $7.23 | $103.5K | 96,790 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2025-01-08 | 2025-01-10 | 10,799 | $8.22 | $88.8K | 89,748 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2025-01-08 | 2025-01-10 | 14,545 | $8.22 | $119.6K | 111,112 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2025-01-08 | 2025-01-10 | 21,172 | $8.22 | $174.0K | 273,616 | SEC↗ |
| Schoch Charles | See Remarks | S Sale | 2025-01-08 | 2025-01-10 | 9,971 | $8.22 | $82.0K | 52,549 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2025-01-08 | 2025-01-10 | 13,673 | $8.22 | $112.4K | 124,207 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-27 | 2024-12-30 | 50,000 | $8.85 | $442.5K | 131,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-27 | 2024-12-30 | 50,000 | $8.85 | $442.5K | 173,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-26 | 2024-12-30 | 50,000 | $9.01 | $450.5K | 181,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-26 | 2024-12-30 | 50,000 | $9.01 | $450.5K | 223,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-24 | 2024-12-26 | 50,000 | $8.82 | $441.0K | 231,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-24 | 2024-12-26 | 50,000 | $8.82 | $441.0K | 273,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-23 | 2024-12-26 | 50,000 | $8.52 | $426.0K | 281,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-23 | 2024-12-26 | 50,000 | $8.52 | $426.0K | 323,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-20 | 2024-12-26 | 100,000 | $9.00 | $900.0K | 373,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-20 | 2024-12-26 | 100,000 | $9.00 | $900.0K | 331,443 | SEC↗ |
| Manning Paul B | Director | P Buy | 2024-12-16 | 2024-12-18 | 750,000 | $6.00 | $4.50M | 1,303,752 | SEC↗ |
| Manning Paul B | Director | P Buy | 2024-12-16 | 2024-12-18 | 500,000 | $6.00 | $3.00M | 1,142,406 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2024-12-12 | 2024-12-13 | 200,000 | $10.04 | $2.01M | 473,512 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2024-12-12 | 2024-12-13 | 200,000 | $10.04 | $2.01M | 431,443 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2024-12-11 | 2024-12-13 | 200,000 | $8.53 | $1.71M | 631,443 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | D To issuer | 2024-12-11 | 2024-12-13 | 200,000 | $8.53 | $1.71M | 673,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-06 | 2024-12-06 | 20,000 | $5.23 | $104.6K | 91,335 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-05 | 2024-12-06 | 20,000 | $4.79 | $95.8K | 111,335 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-12-04 | 2024-12-06 | 20,000 | $4.46 | $89.2K | 131,335 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2024-11-29 | 2024-12-03 | 22,081 | $4.56 | $100.7K | 137,880 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2024-11-29 | 2024-12-03 | 13,935 | $4.56 | $63.5K | 100,547 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2024-11-29 | 2024-12-03 | 48,847 | $4.56 | $222.7K | 294,788 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2024-11-29 | 2024-12-03 | 20,392 | $4.56 | $93.0K | 125,657 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-25 | 2024-11-27 | 20,000 | $4.97 | $99.4K | 151,335 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | M Exercise deriv | 2024-11-21 | 2024-11-21 | 12,900 | — | $0 | 1,763,968 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | M Exercise | 2024-11-21 | 2024-11-21 | 12,900 | $1.55 | $20.0K | 343,635 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-08 | 2024-11-08 | 7,500 | $4.92 | $36.9K | 873,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-08 | 2024-11-08 | 7,500 | $4.92 | $36.9K | 831,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-07 | 2024-11-08 | 7,500 | $5.19 | $38.9K | 881,012 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-07 | 2024-11-08 | 7,500 | $5.19 | $38.9K | 838,943 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-06 | 2024-11-08 | 7,500 | $5.33 | $40.0K | 846,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-06 | 2024-11-08 | 7,500 | $5.33 | $40.0K | 888,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-01 | 2024-11-01 | 7,500 | $5.27 | $39.5K | 853,943 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-11-01 | 2024-11-01 | 7,500 | $5.27 | $39.5K | 896,012 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-31 | 2024-11-01 | 7,500 | $5.30 | $39.8K | 861,443 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-31 | 2024-11-01 | 7,500 | $5.30 | $39.8K | 903,512 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-30 | 2024-11-01 | 6,000 | $5.38 | $32.3K | 868,943 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-30 | 2024-11-01 | 6,000 | $5.38 | $32.3K | 911,012 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-28 | 2024-10-28 | 11,711 | $5.58 | $65.3K | 888,532 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-25 | 2024-10-28 | 1,597 | $5.80 | $9.3K | 900,243 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-24 | 2024-10-28 | 1,194 | $5.72 | $6.8K | 901,840 | SEC↗ |
| Aguilar Laura K. | 10% Owner | D To issuer | 2024-10-24 | 2024-10-28 | 16,427 | $5.53 | $90.8K | 903,034 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-15 | 2024-10-15 | 10,412 | $6.03 | $62.8K | 919,461 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-14 | 2024-10-15 | 15,000 | $6.02 | $90.3K | 929,873 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-11 | 2024-10-15 | 15,000 | $6.05 | $90.8K | 944,873 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-03 | 2024-10-03 | 1,800 | $6.85 | $12.3K | 959,873 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-02 | 2024-10-03 | 26,988 | $6.92 | $186.8K | 961,673 | SEC↗ |
| Aguilar-Cordova Estuardo | 10% Owner | S Sale | 2024-10-01 | 2024-10-03 | 6,214 | $7.01 | $43.6K | 988,661 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2024-07-17 | 2024-07-19 | 14,051 | $6.47 | $90.9K | 159,961 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2024-07-17 | 2024-07-19 | 10,875 | $6.47 | $70.4K | 114,482 | SEC↗ |
| Schoch Charles | See Remarks | S Sale | 2024-07-17 | 2024-07-19 | 9,884 | $6.47 | $63.9K | 62,520 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2024-07-17 | 2024-07-19 | 22,528 | $6.47 | $145.8K | 330,735 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2024-07-17 | 2024-07-19 | 14,851 | $6.47 | $96.1K | 146,049 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | S Sale | 2024-07-11 | 2024-07-15 | 12,645 | $5.97 | $75.5K | 174,012 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | S Sale | 2024-07-11 | 2024-07-15 | 9,769 | $5.97 | $58.3K | 125,357 | SEC↗ |
| Schoch Charles | See Remarks | S Sale | 2024-07-11 | 2024-07-15 | 8,897 | $5.97 | $53.1K | 72,404 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | S Sale | 2024-07-11 | 2024-07-15 | 20,293 | $5.97 | $121.1K | 353,263 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | S Sale | 2024-07-11 | 2024-07-15 | 13,330 | $5.97 | $79.6K | 160,900 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Gaeta Renee | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Martell Christopher | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nabel Gary J. | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nguyen Diem | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Amello Jason | Chief Financial Officer | F Tax w/h | 2023-11-28 | 2023-11-30 | 20,153 | $0.90 | $18.1K | 202,009 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | F Tax w/h | 2023-11-28 | 2023-11-30 | 19,748 | $0.90 | $17.8K | 186,657 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | F Tax w/h | 2023-11-28 | 2023-11-30 | 17,328 | $0.90 | $15.6K | 174,230 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | F Tax w/h | 2023-11-28 | 2023-11-30 | 12,175 | $0.90 | $11.0K | 135,126 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | F Tax w/h | 2023-11-28 | 2023-11-30 | 43,443 | $0.90 | $39.1K | 373,556 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award | 2023-11-26 | 2023-11-28 | 180,108 | — | $0 | 416,999 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award | 2023-11-26 | 2023-11-28 | 125,717 | — | $0 | 222,162 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | A Award | 2023-11-26 | 2023-11-28 | 104,516 | — | $0 | 191,558 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award | 2023-11-26 | 2023-11-28 | 88,822 | — | $0 | 147,301 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award | 2023-11-26 | 2023-11-28 | 112,790 | — | $0 | 206,405 | SEC↗ |
| Nabel Gary J. | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Aguilar-Cordova Estuardo | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nguyen Diem | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Gaeta Renee | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Martell Christopher | Director | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Loggia Nicoletta | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 28,480 | — | $0 | 28,480 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award deriv | 2023-04-28 | 2023-05-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award deriv | 2023-04-28 | 2023-05-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award deriv | 2023-04-28 | 2023-05-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | A Award deriv | 2023-04-28 | 2023-05-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award deriv | 2023-04-28 | 2023-05-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Martell Christopher | Director | P Buy | 2022-12-09 | 2023-02-17 | 23,950 | $1.92 | $46.0K | 152,000 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | P Buy | 2022-12-09 | 2022-12-12 | 12,935 | $1.92 | $24.8K | 40,985 | SEC↗ |
| Amello Jason | Chief Financial Officer | P Buy | 2022-12-09 | 2022-12-12 | 2,468 | $1.93 | $4.8K | 5,568 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | P Buy | 2022-12-09 | 2022-12-12 | 10,358 | $1.93 | $20.0K | 13,358 | SEC↗ |
| Martell Christopher | Director | P Buy | 2022-12-09 | 2022-12-12 | 23,950 | $1.92 | $46.0K | 152,000 | SEC↗ |
| PAPA JOSEPH C | Director | P Buy | 2022-12-09 | 2022-12-12 | 35,018 | $1.94 | $67.9K | 38,032 | SEC↗ |
| Martell Christopher | Director | P Buy | 2022-12-08 | 2023-02-17 | 3,050 | $1.68 | $5.1K | 128,050 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | P Buy | 2022-12-08 | 2022-12-12 | 3,050 | $1.70 | $5.2K | 28,050 | SEC↗ |
| Amello Jason | Chief Financial Officer | P Buy | 2022-12-08 | 2022-12-12 | 3,100 | $1.69 | $5.2K | 3,100 | SEC↗ |
| Tyagarajan Seshu | Chief Technology Officer | P Buy | 2022-12-08 | 2022-12-12 | 3,000 | $1.69 | $5.1K | 3,000 | SEC↗ |
| Martell Christopher | Director | P Buy | 2022-12-08 | 2022-12-12 | 3,050 | $1.68 | $5.1K | 128,050 | SEC↗ |
| PAPA JOSEPH C | Director | P Buy | 2022-12-08 | 2022-12-12 | 3,014 | $1.70 | $5.1K | 3,014 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | P Buy | 2022-12-08 | 2022-12-12 | 1,238 | $1.61 | $2.0K | 2,738 | SEC↗ |
| Tyagarajan Seshu | See Remarks | A Award | 2022-11-28 | 2022-11-30 | 73,684 | — | $0 | 73,684 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award | 2022-11-28 | 2022-11-30 | 58,479 | — | $0 | 58,479 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award | 2022-11-28 | 2022-11-30 | 90,877 | — | $0 | 92,377 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award | 2022-11-28 | 2022-11-30 | 195,906 | — | $0 | 220,906 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award | 2022-11-28 | 2022-11-30 | 90,877 | — | $0 | 90,877 | SEC↗ |
| Manning Paul B | Director | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Nguyen Diem | Director | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Martell Christopher | Director | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Aguilar-Cordova Estuardo | Director | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award deriv | 2022-09-21 | 2022-09-23 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Nichols William Garrett | Chief Medical Officer | A Award deriv | 2022-09-12 | 2022-09-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PAPA JOSEPH C | Director | A Award deriv | 2022-08-08 | 2022-08-10 | 28,480 | — | $0 | 28,480 | SEC↗ |
| Nabel Gary J. | Director | A Award deriv | 2022-08-08 | 2022-08-10 | 28,480 | — | $0 | 28,480 | SEC↗ |
| Gaeta Renee | Director | A Award deriv | 2022-08-08 | 2022-08-10 | 28,480 | — | $0 | 28,480 | SEC↗ |
| Aguilar-Cordova Estuardo | Director, 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 46,261 | — | $0 | 30,456 | SEC↗ |
| Aguilar-Cordova Estuardo | Director, 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 12,205 | — | $0 | 0 | SEC↗ |
| Aguilar-Cordova Estuardo | Director, 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 76,717 | — | $0 | 0 | SEC↗ |
| Aguilar Laura K. | 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 76,717 | — | $0 | 0 | SEC↗ |
| Aguilar Laura K. | 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 76,717 | — | $0 | 0 | SEC↗ |
| Aguilar Laura K. | 10% Owner | M Exercise deriv | 2022-05-06 | 2022-05-10 | 17,901 | — | $0 | 0 | SEC↗ |
| Aguilar-Cordova Estuardo | Director, 10% Owner | F Tax w/h | 2022-05-06 | 2022-05-10 | 54,074 | $3.65 | $197.4K | 1,097,032 | SEC↗ |
| Aguilar-Cordova Estuardo | Director, 10% Owner | M Exercise | 2022-05-06 | 2022-05-10 | 135,183 | $1.46 | $197.4K | 1,151,106 | SEC↗ |
| Aguilar Laura K. | 10% Owner | M Exercise | 2022-05-06 | 2022-05-10 | 171,335 | $1.46 | $250.1K | 1,102,374 | SEC↗ |
| Aguilar Laura K. | 10% Owner | F Tax w/h | 2022-05-06 | 2022-05-10 | 68,534 | $3.65 | $250.1K | 1,033,840 | SEC↗ |
| Tyagarajan Seshu | See Remarks | A Award deriv | 2022-04-14 | 2022-04-15 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Stewart Susan B. | Chief Regulatory Officer | A Award deriv | 2022-04-11 | 2022-04-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award deriv | 2022-02-28 | 2022-03-01 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | A Award deriv | 2022-02-28 | 2022-03-01 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Canepa John J | Chief Financial Officer | A Award deriv | 2022-02-28 | 2022-03-01 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Barone Francesca | Chief Scientific Officer | A Award deriv | 2022-02-03 | 2022-02-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Aguilar Laura K. | Chief Medical Officer | C Conversion deriv | 2021-07-29 | 2021-08-02 | 137,881 | — | $0 | 0 | SEC↗ |
| Manning Paul B | Director | C Conversion deriv | 2021-07-29 | 2021-08-02 | 1,361,069 | — | $0 | 0 | SEC↗ |
| Manning Paul B | Director | C Conversion deriv | 2021-07-29 | 2021-08-02 | 1,669,303 | — | $0 | 0 | SEC↗ |
| Aguilar-Cordova Estuardo | Chief Scientific Officer | C Conversion deriv | 2021-07-29 | 2021-08-02 | 398,519 | — | $0 | 0 | SEC↗ |
| Martell Christopher | Director | C Conversion deriv | 2021-07-29 | 2021-08-02 | 696,851 | — | $0 | 0 | SEC↗ |
| Manning Paul B | Director, 10% Owner | C Conversion deriv | 2021-07-29 | 2021-08-04 | 1,361,069 | — | $0 | 0 | SEC↗ |
| Manning Paul B | Director, 10% Owner | C Conversion deriv | 2021-07-29 | 2021-08-04 | 1,669,303 | — | $0 | 0 | SEC↗ |
| Manning Paul B | Director | P Buy | 2021-07-29 | 2021-07-29 | 20,000 | $7.30 | $146.0K | 56,000 | SEC↗ |
| Caffo Nathan | Chief Business Officer | P Buy | 2021-07-29 | 2021-08-02 | 6,000 | $8.00 | $48.0K | 6,000 | SEC↗ |
| Aguilar Laura K. | Chief Medical Officer | C Conversion | 2021-07-29 | 2021-08-02 | 56,096 | — | $0 | 931,039 | SEC↗ |
| Canepa John J | Chief Financial Officer | P Buy | 2021-07-29 | 2021-08-02 | 10,125 | $8.00 | $81.0K | 10,125 | SEC↗ |
| Manning Paul B | Director | C Conversion | 2021-07-29 | 2021-08-02 | 553,752 | — | $0 | 553,752 | SEC↗ |
| Manning Paul B | Director | C Conversion | 2021-07-29 | 2021-08-02 | 679,158 | — | $0 | 679,158 | SEC↗ |
| Tak Paul Peter | Chief Executive Officer | P Buy | 2021-07-29 | 2021-08-02 | 25,000 | $8.00 | $200.0K | 25,000 | SEC↗ |
| Nguyen Diem | Director | P Buy | 2021-07-29 | 2021-08-02 | 10,000 | $8.00 | $80.0K | 10,000 | SEC↗ |
| Aguilar-Cordova Estuardo | Chief Scientific Officer | C Conversion | 2021-07-29 | 2021-08-02 | 162,137 | — | $0 | 1,015,923 | SEC↗ |
| Martell Christopher | Director | P Buy | 2021-07-29 | 2021-08-02 | 125,000 | $8.00 | $1.00M | 125,000 | SEC↗ |
| Martell Christopher | Director | C Conversion | 2021-07-29 | 2021-08-02 | 283,514 | — | $0 | 283,514 | SEC↗ |
| Manning Paul B | Director, 10% Owner | P Buy | 2021-07-29 | 2021-08-04 | 1,625,000 | $8.00 | $13.00M | 1,681,000 | SEC↗ |
| Manning Paul B | Director, 10% Owner | C Conversion | 2021-07-29 | 2021-08-04 | 679,158 | — | $0 | 679,158 | SEC↗ |
| Manning Paul B | Director, 10% Owner | C Conversion | 2021-07-29 | 2021-08-04 | 553,752 | — | $0 | 553,752 | SEC↗ |
| Manning Paul B | Director | P Buy | 2021-07-27 | 2021-07-29 | 36,000 | $7.36 | $265.0K | 36,000 | SEC↗ |